Affluent Medical (AFME) | Stock Overview & Key Data
Affluent Medical Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €8.60 on June 14, 2021
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Affluent Medical
AFME
|
122.22M Small-cap | -4.82% | 9.09% | 26.32% | 134.97% | 88.76% | 146.48% | 171.32% | -55.97% | -55.97% | -55.97% | -55.97% |
|
Eurobio Scientific
ALERS
|
229.56M Mid-cap | 1.34% | 1.34% | 0.89% | -6.39% | -6.00% | -12.55% | 52.53% | 19.00% | 178.75% | -5.51% | -5.51% |
|
Median Technologies
ALMDT
|
188.62M Mid-cap | -3.32% | 0.00% | 2.91% | 52.78% | 12.76% | 141.21% | -23.08% | -60.40% | -44.83% | -35.48% | -35.48% |
|
Guerbet S.A
GBT
|
127.29M Small-cap | -4.57% | -1.21% | 19.63% | -27.01% | -33.63% | -53.04% | -42.84% | -67.54% | -81.86% | -38.17% | -38.17% |
|
Mauna Kea
ALMKT
|
37.44M Small-cap | 0.00% | -5.56% | -15.00% | 142.86% | 112.50% | 30.77% | -72.58% | -72.58% | -72.58% | -72.58% | -72.58% |
|
Diagnostic Medical
ALDMS
|
34.47M Small-cap | 6.56% | 0.00% | 2.36% | 4.84% | 1.56% | 3.23% | -10.49% | -15.23% | -28.89% | -39.91% | -39.91% |
Ownership & Short Interest
Calculate Your Affluent Medical Investment Returns
Long-Term Investment Performance Analysis
Affluent Medical stock price in Jun 2021 was €7.95, A €1,000.00 lump sum investment in Affluent Medical made 5 years ago would be worth approximately €422.64 today, representing a negative return of -57.74%. This translates to an annualized return (CAGR) of -15.82%.
5 Years Investment Scenario (Jun 2021 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is AFME's 52-week high and low?
- In the last 52 weeks, Affluent Medical reached a high of €5.22 (on February 6, 2026) and a low of €1.16 (on June 30, 2025).
- What is the market cap and P/E ratio for AFME?
- Curious about Affluent Medical's size and valuation? Its market capitalization stands at 122.22M. When it comes to valuation, the P/E ratio (trailing twelve months) is -8.37, and the forward P/E (looking ahead) is -6.32.
- Does AFME pay dividends? If so, what's the yield?
- As for dividends, Affluent Medical isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Affluent Medical's main competitors or similar companies to consider before investing?
When looking at Affluent Medical, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Eurobio Scientific
ALERS229.56M Healthcare Medical Devices -12.55% 52.53% Median Technologies
ALMDT188.62M Healthcare Medical Devices 141.21% -23.08% Guerbet S.A
GBT127.29M Healthcare Medical Devices -53.04% -42.84% Mauna Kea
ALMKT37.44M Healthcare Medical Devices 30.77% -72.58% Diagnostic Medical
ALDMS34.47M Healthcare Medical Devices 3.23% -10.49% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Affluent Medical S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Affluent Medical's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -62.51%, the Debt to Equity ratio from the most recent quarter is 110.96, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for AFME?
- Looking at Affluent Medical's growth, its revenue over the trailing twelve months (TTM) was €5M. Compared to the same quarter last year (YoY), quarterly revenue grew by -12.70%, and quarterly earnings saw a YoY growth of N/A.
- How much of AFME stock is held by insiders and institutions?
- Wondering who owns Affluent Medical stock? Company insiders (like executives and directors) hold about 21.86% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 60.32%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.